Seven and Eight Biopharmaceuticals

North America Legal Chronicle. June 23, 2023

Seven and Eight Biopharmaceuticals’ License Agreement with Eikon Therapeutics

By Pietro Martinoia

Cooley advised Seven and Eight Biopharmaceuticals on the deal. Seven and Eight Biopharmaceuticals Inc. announced that it has signed an exclusive licensing agreement with Eikon Therapeutics....

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Lean Technologies’ $67.5 Million Series B Funding

Celsius Holdings’ $75 Million Acquisition of Big Beverages Contract Manufacturing

Charter Communications’ Acquisition of Liberty Broadband Corporation

LHG Mining’s R$3.6 Billion Financing

CCR and Neoenergia’s Agreement for Self-Production Project

CNH Industrial Capital Argentina’s US$28 Million Notes Issuance

Galileo Green Energy’s Acquisition Of Renewable Projects From Quenea’ch

EQT X’s Acquisition of OEM International

Cloudsquid’s $1 Million Pre-Seed Financing Round

TE H2, CIP, and A.P. Moller Capital’s Developmente Of Large-Scale Green Hydrogen Project In Morocco

Camusat Holding’s €81 Million Mezzanine Investment Round

Retail Holding’s Shareholders Reconfiguration

Polyrizon’s $4.2 Million Initial Public Offering

Gordon Technologies’ Acquisition of Vertex Downhole Trading

Nala Renewables’ Financing Of 99.2MW Onshore Wind Project In Romania

Intudo’s US$125 Million Closing of Intudo Ventures IV and Natural Resources Fund

Downhole Products Limited’s Acquisition of Sledgehammer Oil Tools Private Limited

LGT Crestone’s Acquisition of Commonwealth Private Advice

Aloke Chakravarty Joins Saul Ewing’s Boston Office

Demarest announces new Dispute Resolution partner

Venture Financing Partner N. Danny Shulman Joins Honigman in Washington

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

Aloke Chakravarty Joins Saul Ewing’s Boston Office

Demarest announces new Dispute Resolution partner

Venture Financing Partner N. Danny Shulman Joins Honigman in Washington

Seven and Eight Biopharmaceuticals’ License Agreement with Eikon Therapeutics

Standard 1 Year Membership Required